Literature DB >> 16540406

Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.

Anne M Koivisto1, Seppo Helisalmi, Jussi Pihlajamäki, Leena Moilanen, Johanna Kuusisto, Markku Laakso, Mikko Hiltunen, Koivisto Keijo, Tuomo Hänninen, Eeva-Liisa Helkala, Kari Kervinen, Y Antero Kesäniemi, Hilkka Soininen.   

Abstract

Recently, the involvement of the inflammatory response in Alzheimer's disease (AD) has received considerable attention. The gene encoding for interleukin-6 (IL-6) is interesting since IL-6 has been reported not only to be involved in immune functions but also in AD. We investigated whether the IL-6-174 G/C polymorphism is associated with late onset AD (LOAD) in the Finnish subjects. The G allele was over-represented in ApoE4-LOAD patients but remained unimportant in all and in the ApoE E4 carriers. Interestingly, the G allele frequency was lower in our population in both AD patients and in controls compared to Southern European populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16540406     DOI: 10.1080/01677060600569721

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  7 in total

Review 1.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

Review 2.  Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis.

Authors:  Limeng Dai; Dan Liu; Hong Guo; Yanyan Wang; Yun Bai
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

Review 3.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

4.  Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans.

Authors:  S Taudorf; K S Krabbe; R M G Berg; K Møller; B K Pedersen; H Bruunsgaard
Journal:  Clin Exp Immunol       Date:  2008-02-25       Impact factor: 4.330

5.  IL-6-174 G/C and -572 C/G polymorphisms and risk of Alzheimer's disease.

Authors:  Hui-Ping Qi; Zheng-Yi Qu; Shu-Rong Duan; Shu-Qin Wei; Shi-Rong Wen; Sheng Bi
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

6.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

7.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.